GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have earned a consensus recommendation of “Moderate Buy” from the nineteen analysts that are currently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $80.20.

GEHC has been the subject of a number of research reports. Piper Sandler reduced their target price on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Rothschild & Co Redburn reduced their price objective on GE HealthCare Technologies from $110.00 to $98.00 in a report on Thursday, April 30th. BTIG Research lowered their target price on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Finally, The Goldman Sachs Group reiterated a “neutral” rating on shares of GE HealthCare Technologies in a research note on Monday, June 8th.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC traded up $0.24 during trading on Tuesday, reaching $65.08. The company’s stock had a trading volume of 214,942 shares, compared to its average volume of 4,347,946. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77. The firm has a market cap of $29.60 billion, a price-to-earnings ratio of 15.60, a price-to-earnings-growth ratio of 1.78 and a beta of 0.72. The firm has a 50 day moving average of $63.60 and a 200-day moving average of $73.09. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the firm posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts expect that GE HealthCare Technologies will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be paid a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.35%.

Insider Buying and Selling

In other GE HealthCare Technologies news, Director Kevin Lobo acquired 10,000 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 22nd. The stock was acquired at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the purchase, the director owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This represents a 229.20% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Watkin Phoebe L. Yang bought 1,000 shares of the stock in a transaction on Friday, May 8th. The shares were acquired at an average cost of $63.01 per share, for a total transaction of $63,010.00. Following the acquisition, the director directly owned 13,702 shares in the company, valued at approximately $863,363.02. This trade represents a 7.87% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have purchased 21,847 shares of company stock valued at $1,361,355. Corporate insiders own 0.36% of the company’s stock.

Institutional Trading of GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after purchasing an additional 267,058 shares during the period. Auto Owners Insurance Co increased its position in shares of GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after buying an additional 33,629,559 shares during the period. Dodge & Cox lifted its holdings in shares of GE HealthCare Technologies by 13.4% in the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock worth $2,559,945,000 after buying an additional 3,693,918 shares in the last quarter. Capital Research Global Investors boosted its position in shares of GE HealthCare Technologies by 1.6% in the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after acquiring an additional 389,796 shares during the period. Finally, State Street Corp boosted its position in shares of GE HealthCare Technologies by 2.0% in the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after acquiring an additional 401,932 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.